Drug profile · INN
lincomycin hydrochloride
LINCOMYCIN HCL
lincomycin hydrochloride (LINCOMYCIN HCL) is a 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — lincomycin hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
lincomycin hydrochloride (LINCOMYCIN HCL) is a 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
70S ribosome inhibitor
Primary target: 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is lincomycin hydrochloride?
lincomycin hydrochloride (LINCOMYCIN HCL) is a 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for lincomycin hydrochloride?
LINCOMYCIN HCL is a marketed brand name for lincomycin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lincomycin hydrochloride?
lincomycin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.